Fast Market Research

Market Report, "Global Epinephrine Autoinjector Market 2017-2021", Published

Fast Market Research announces the availability of the new TechNavio report, "Global Epinephrine Autoinjector Market 2017-2021", on their comprehensive research portal


Boston, MA -- (SBWIRE) -- 04/24/2017 -- Epinephrine is among the first line of treatment drugs for anaphylactic conditions and is considered a life-saving drug during emergencies. Epinephrine autoinjectors have proved to be a life savior for people with severe allergies from as early as the 1980s. The global epinephrine autoinjector market has been witnessing continuous technological innovations and developments over the years, after the first FDA approval of EpiPen in 1987.

Technavio's analysts forecast the global epinephrine autoinjector market to grow at a CAGR of 14.58% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global epinephrine autoinjector market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various epinephrine autoinjectors to key end-users such as hospitals, clinics, and individuals.
The market is divided into the following segments based on geography:

Get More Details on this Report and a Full Table of Contents at Global Epinephrine Autoinjector Market 2017-2021


Technavio's report, Global Epinephrine Autoinjector Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-Impax Laboratories
-Lincoln Medical

Other prominent vendors

-Adamis Pharmaceuticals
-Antares Pharma
-Kaleo Pharma
-Teva Pharmaceutical Industries

Market driver

-Increasing prevalence of allergies
-For a full, detailed list, view our report

Market challenge

-Product recalls and regulatory issues
-For a full, detailed list, view our report

Market trend

-Tentative product launches
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: ALK-Abelló, Impax Laboratories, Lincoln Medical, Mylan, Adamis Pharmaceuticals, Antares Pharma, Emerade, Hospira, Kaleo Pharma, Teva Pharmaceutical Industries

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance
-Pharmaceutical Excipients Market - Global Forecast to 2021
-Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
-Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market
-Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth